Category Archive: Controlled release

Sep 02

BIPH Affiliates Perez Romero and Nallathamby Receive NIH/NIAID R21 Award for Precision CMV Antiviral Delivery

Categories:

Antiviral, Controlled release, Nallathamby Lab

by

Congratulations to BIPH affiliates Prof. Maria Del Pilar Perez Romero (Department of Biological Sciences) and Prof. Prakash D. Nallathamby (Berthiaume Institute for Precision Health; Aerospace and Mechanical Engineering) on receiving an NIH/NIAID R21 award, “Monoclonal Antibody-Conjugated Nanoparticles for Precision CMV Antiviral Delivery” (R21AI203022). Cytomegalovirus (CMV) is one of the most clinically significant yet overlooked viral …

Continue reading »

Tags: , , ,

Aug 21

Sustained and Controlled Antibiotics Release for Prolonged Antibacterial Action Against MRSA, and Pseudomonas aeruginosa

Categories:

Antimicrobial, Berthiaume Institute for Precision Health, Controlled release, Uncategorized

by

Congratulations to REUs Argerie Guevara (NURF’21), and Kevin Armknecht (NURF’23) and Carlie Kudary (#BIPH) on the prolonged antibacterial action formulation of standard antibiotics to tackle MRSA and P.aeruginosa. More to come this year. #AMR #GOIRISH https://doi.org/10.1093/milmed/usae079

Tags: , ,